| Univariate P | Multivariate P | Hazard ratio | 95% Confidence interval |
---|---|---|---|---|
pL | 0.011 | 0.922 | Â | Â |
Negative/Positive | Â | Â | Â | Â |
pV | 0.016 | 0.742 | Â | Â |
Negative/Positive | Â | Â | Â | Â |
Hepatic metastases | 0.043 | 0.116 | Â | Â |
Negative/Positive | Â | Â | Â | Â |
pT | <0.001 | 0.123 | Â | Â |
T1,2/ pT3,4 | Â | Â | Â | Â |
Differentiation | 0.011 | 0.201 | Â | Â |
Poor/ Moderate/ Well | Â | Â | Â | Â |
pStage | <0.001 | 0.010 | 1.642 | 1.124-2.400 |
I / II / III,IV | Â | Â | Â | Â |
MMP-9 expression | 0.005 | 0.938 | Â | Â |
Negative/Positive | Â | Â | Â | Â |
TN-C expression | 0.019 | 0.766 | Â | Â |
Negative/Positive | Â | Â | Â | Â |
fTN-C expression | 0.033 | 0.978 | Â | Â |
Negative/Positive | Â | Â | Â | Â |
MMP-9, TN-C expression | <0.001 | 0.042 | 1.727 | 1.019-2.927 |
Negative/Positive | Â | Â | Â | Â |